Sign In
Buy CPRX
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
CPRX vs. NBIX: Which Stock Is the Better Value Option?
12:41pm, Monday, 23'rd Jun 2025
Investors with an interest in Medical - Drugs stocks have likely encountered both Catalyst Pharmaceutical (CPRX) and Neurocrine Biosciences (NBIX). But which of these two stocks offers value investors
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
10:45am, Thursday, 19'th Jun 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock
10:45am, Wednesday, 18'th Jun 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
4 Stocks With Solid Net Profit Margins to Boost Portfolio Returns
09:25am, Tuesday, 17'th Jun 2025
Here we present four stocks, GLDD, TILE, CPRX and STRL, with solid net profit margins that can contribute to making a strong portfolio.
Strong Inflows Make Catalyst Stock an Outlier
07:08am, Wednesday, 11'th Jun 2025
Catalyst Pharmaceuticals, Inc. (CPRX), keeps growing, bringing in Big Money.
Catalyst Pharmaceuticals, Inc. (CPRX) Hits Fresh High: Is There Still Room to Run?
10:16am, Tuesday, 10'th Jun 2025
Catalyst (CPRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Catalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 06'th Jun 2025
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock?
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
10:56am, Friday, 06'th Jun 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
What Makes Catalyst Pharmaceutical (CPRX) a Strong Momentum Stock: Buy Now?
01:01pm, Wednesday, 04'th Jun 2025
Does Catalyst Pharmaceutical (CPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
CPRX or NBIX: Which Is the Better Value Stock Right Now?
12:40pm, Tuesday, 03'rd Jun 2025
Investors looking for stocks in the Medical - Drugs sector might want to consider either Catalyst Pharmaceutical (CPRX) or Neurocrine Biosciences (NBIX). But which of these two stocks is more attracti
Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term
10:46am, Tuesday, 03'rd Jun 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Does Catalyst (CPRX) Have the Potential to Rally 36.22% as Wall Street Analysts Expect?
11:01am, Monday, 02'nd Jun 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 36.2% in Catalyst (CPRX). While the effectiveness of this highly sought-after metric is questionable, the posit
Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term
10:46am, Monday, 02'nd Jun 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Catalyst (CPRX) Is a Great Choice for 'Trend' Investors, Here's Why
09:56am, Monday, 02'nd Jun 2025
Catalyst (CPRX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our
Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer
08:03am, Monday, 02'nd Jun 2025
Gary Ingenito, MD, PhD is retiring from Catalyst after a successful career Gary Ingenito, MD, PhD is retiring from Catalyst after a successful career
